Live Update 
From the Liveblog of
Wednesday, March 22, 2023
From the Liveblog of
Wednesday, March 22, 2023
BioNTech to build factory in Jerusalem to develop and produce vaccines
Add ToI as a Preferred Source on Google
A technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)
BioNTech, the German biotech company that formulated the COVID vaccine sold by Pfizer, signs a memorandum of understanding to build a new facility in Jerusalem to develop and produce vaccines.
The center, to be located in the Har Hotzvim area of the capital, will focus on mRNA technologies for medications and vaccinations to fight cancer and possible future pandemics. The agreement also gives Israel the ability to be the first to purchase vaccines in the case of a pandemic outbreak.
A representative of BioNTech signs the memorandum in the capital with Jerusalem Mayor Moshe Lion, as well as Health and Finance ministry officials.
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here